BioNTech announced on June 2, 2023 the start of its new share buyback program announced in March 2023. The Company intends to repurchase own shares in an amount of up to $0.5 billion until November 2, 2023. Announcement pursuant to Art 5 (1)a) EU Regulation 596_2014 and Art 2 (1) EU Delegated Regulation 2016_1052_Share …BioNTech SE Sponsored ADR (BNTX) closed at $130.86 in the latest trading session, marking a -1.84% move from the prior day. This change lagged the S&P 500's daily gain of 0.31%.BioNTech plans to initiate a pivotal Phase 2 trial in relapsed/refractory germ cell tumors in 2024. In 2024, BioNTech intends to accelerate the development of its portfolio of next-generation investigational medicines both as monotherapies and in combination with immunotherapy agents and other targeted therapies across a wide range of tumor types.Aug 20, 2020 ... NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today shared additional Phase 1 safety and ...In depth view into BNTX (BioNTech) stock including the latest price, news, dividend history, earnings information and financials. ... BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including …Track BioNTech SE - ADR (BNTX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsGet the latest BioNTech SE - ADR (BNTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment …BioNTech invites investors and the general public to join a conference call and webcast with investment analysts today, November 6, 2023, at 8.00 a.m. ET (2.00 p.m. CET) to report its financial results and provide a corporate update for the third quarter of 2023. To access the live conference call via telephone, please register via this link. Find the latest BioNTech SE (22UA.F) stock quote, history, news and other vital information to help you with your stock trading and investing. 80.90%. -16.75%. -163.26%. -35.78%. -95.66%. Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC). Detailed annual and quarterly income statement for BioNTech SE (BNTX). See many years of revenue, expenses and profits or losses.Is BioNTech Stock a Buy? By Jason Hawthorne – Mar 5, 2021 at 7:44AM You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services.BioNTech, founded in 2008 by Ugur Sahin and Özlem Türeci, is a German biotechnology company focused on developing individualized cancer immunotherapies and mRNA vaccines. The company's ... Q1 2024 BioNTech SE Earnings Call. Find the latest BioNTech SE (BNTX) stock quote, history, news and other vital information to help you with your stock trading and investing. MAINZ, Germany, and ROCKVILLE, Maryland, USA, June 29, 2023 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, “BioNTech”) and OncoC4, Inc. (“OncoC4”) today announced that the first patient with non-small cell lung cancer (NSCLC) has been treated in a pivotal Phase 3 trial evaluating the companies’ next-generation anti-CTLA-4 …Because of that gap in time -- and the risk of failures during clinical trials -- determining whether BioNTech stock is a buy is less about valuation and more about the open-ended potential of a ...The clinical milestone is in furtherance of BioNTech’s and DualityBio’s strategic objective to advance BNT323/DB-1303 into late-stage ... As concerns over stock market volatility ...Get the latest BioNTech SE - ADR (BNTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.The average 12-month price target for BioNTech stock right now is $261.95, roughly 25% lower than the current share price. That average is based on Refinitiv's survey of 12 analysts.Moderna and BioNTech are no longer minting money from Covid vaccines. But both have strong drug pipelines and plenty of cash.BioNTech SE (/ b iː ˈ ɒ n t ɛ k / bee-ON-tek; or / b aɪ ˈ ɒ n t ɛ k / bye-ON-tek short for Biopharmaceutical New Technologies) is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases. It develops pharmaceutical candidates based on messenger …Complete BioNTech SE ADR stock information by Barron's. View real-time BNTX stock price and news, along with industry-best analysis.BioNTech’s stock sinks after earnings miss, as inventory writedowns weigh Mar. 20, 2024 at 7:30 a.m. ET by Tomi Kilgore Biontech 4Q Rev EUR1.48BOpen. $92.59. Previous Close- YTD Change. -11.69% 12 Month Change. -11.44% Day Range92.42 - 93.20. 52 Wk Range85.21 - 125.83. Volume. 64.12K (10.74% of Avg) 65 …BNTX: Biontech SE - Stock Price, Quote and News - CNBC. Biontech SE BNTX:NASDAQ. EXPORT. WATCHLIST +. RT Quote | Last NYSE Arca, VOL From …BioNTech SE. An der Goldgrube 12. 55131 Mainz, Deutschland. T: +49 6131 9084-0. F: +49 6131 9084-2121. [email protected]. Unternehmen. Über uns Forschung & Innovation Unsere Pipeline Produktion Karriere COVID-19. Quick Links. News Investoren Medizinisches Fachpersonal Connect.Mar 20, 2024 · BioNTech reported Q4 2023 earnings below expectations, with EPS at €1.90 vs. €9.26 last year. Sales were €1.479 billion, missing consensus. Guidance for 2024 anticipates revenues of €2.5 ... Shares of BioNTech SE BNTX, +0.58% dropped 2.4% toward a three-month low in premarket trading Monday, after the Germany-based biotechnology company, which developed a COVID-19 vaccine with partner ...In addition, BioNTech SE Sponsored ADR has a VGM Score of D (this is a weighted average of the individual Style Scores which allow you to focus on the stocks that best fit your personal trading ...Jun 21, 2023 ... BioNTech SE(NASDAQ:BNTX): Amidst the biotech industry's rapid growth and notable advancements, let's analyze which of the two major players, ...4.2100. -5.61%. Find the latest BioNTech SE (BNTX) stock quote, history, news and other vital information to help you with your stock trading and investing.BioNTech SE(NASDAQ:BNTX): Amidst the biotech industry’s rapid growth and notable advancements, let’s analyze which of the two major players, ... Among the 386 stocks in the Biotech industry, MRNA is ranked #62, while BNTX is ranked #27. Beyond what is stated above, we have also rated the stocks for Value, Growth, ...It’s no secret that investors want to achieve stock market success when they start trading shares — but doing so largely comes down to figuring out the best stocks to invest in and...BioNTech, a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, has seen its stock rally from about $80 at the end of 2020 to levels of almost $420 currently, marking an ...May 10, 2024 · BioNTech’s stock sinks after earnings miss, as inventory writedowns weigh Mar. 20, 2024 at 7:30 a.m. ET by Tomi Kilgore Biontech 4Q Rev EUR1.48B BioNTech (BNTX) to Report Q2 Earnings: What's in the Cards? Why BioNTech Stock Soared 66% in March While the Market Plunged Nasdaq. If You Invested $10,000 in ...BioNTech, a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, has seen its stock decline by almost 9.4% over the last week (five trading days) and by about 17% over the ...Pfizer's success in the COVID-19 vaccine space, thanks in part to its partner BioNTech, has helped the company's stock price soar above its previous record last seen in 1999.On June 6, 2022, Pfizer announced that it was investing $120 million in COVID-19 treatment Paxlovid. On May 3, 2022, Pfizer announced Q1 FY 2022 financial results. Revenue rose 77% year-over-year ...BioNTech stock, a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, declined by almost 31% over the last month, considerably underperforming the S&P 500 which remained ...Answering this question will take us one step closer to our new normal. We know that the vaccines now available across the world will protect their recipients from getting sick wit...Complete BioNTech SE ADR stock information by Barron's. View real-time BNTX stock price and news, along with industry-best analysis.On today's stock market, BNTX stock dipped 0.4% and closed at 108.05. BNTX Stock: Lower Boosting Levels Expected. The Pfizer -partnered Covid shot is BioNTech's only commercial product. BioNTech's ...Monday, BioNTech SE (NASDAQ:BNTX) reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the consensus loss of 97 cents. The COVID-19 vaccine ...Mar 20, 2024 · BioNTech reported Q4 2023 earnings below expectations, with EPS at €1.90 vs. €9.26 last year. Sales were €1.479 billion, missing consensus. Guidance for 2024 anticipates revenues of €2.5 ... According to the issued ratings of 11 analysts in the last year, the consensus rating for BioNTech stock is Hold based on the current 1 sell rating, 6 hold ratings and 4 buy ratings for BNTX. The average twelve-month price prediction for BioNTech is $117.25 with a high price target of $171.00 and a low price target of $90.00.BioNTech has had an excellent 2021. 2022 and beyond will most likely not be this good, however. See if BNTX stock is a buy or sell after earnings.BioNTech’s announcement came after Pfizer cut its guidance for the Covid vaccine, ... The stock fell another 3 per cent to $31.13 in US pre-market trading on Monday.Jan 20, 2022 · BioNTech stock, a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, declined by almost 31% over the last month, considerably underperforming the S&P 500 which remained ... About BioNTech SE. BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June ...The clinical milestone is in furtherance of BioNTech’s and DualityBio’s strategic objective to advance BNT323/DB-1303 into late-stage ... As concerns over stock market volatility ...Stock Market News, March 11, 2024: S&P 500 Closes Lower; Bitcoin Rallies Above $72,000 ... Shares of Moderna and BioNTech rose on Monday after two tantalizing morsels hinted at their potential for ...Nov 6, 2023 · (RTTNews) - BioNTech SE (BNTX) Monday announced a sharp fall in third-quarter earnings compared to the prior year, as the commercial revenues were down sharply. The company revised down its COVID ... A major windfall. Based in Germany, BioNTech was originally founded in 2008 and made its debut on the stock market in the U.S. in late 2019. It was a relatively unknown company then, but its ...Discover real-time BioNTech SE American Depositary Share (BNTX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq. Find the latest BioNTech SE (22UA.F) stock quote, history, news and other vital information to help you with your stock trading and investing. Open 84.75. Bid 84.35 x -- Ask 86.05 x -- Day's Range 84.75 - 86.00. 52 Week Range 77.50 - 116.00. Volume 106. Avg. Volume 1,190. Market Cap (intraday) 20.713B. Beta …That's why it's important to consider a stock like BioNTech (BNTX 1.59%). Sure, the stock has climbed 962% since the beginning of last year. But a lot has happened since. The company's future ...BioNTech (BNTX) to Report Q2 Earnings: What's in the Cards? Why BioNTech Stock Soared 66% in March While the Market Plunged Nasdaq. If You Invested $10,000 in ...The latest closing stock price for BioNTech SE as of May 10, 2024 is 91.67. The all-time high BioNTech SE stock closing price was 441.35 on August 09, 2021. The BioNTech SE 52-week high stock price is 125.83, which is 37.3% above the current share price. The BioNTech SE 52-week low stock price is 85.21, which is 7% below the current share price ...Discover historical prices for BNTX stock on Yahoo Finance. View daily, weekly or monthly format back to when BioNTech SE stock was issued.BNTX. -0.47%. On Monday, Evercore ISI began coverage on shares of BioNTech (NASDAQ: BNTX ), assigning an "In Line" rating and setting a price target of $100. The firm's analysis pointed to the ...Mar 20, 2024 ... Shares of Pfizer rose a fraction to 27.70. BioNTech Stock Faces Continues Declines. Despite launching new booster shots to target more updated ...BioNTech invites investors and the general public to join a conference call and webcast with investment analysts today, May 8, 2023 at 8.00 a.m. EDT (2.00 p.m. CEST) to report its financial ...Insights from analysts' 12-month price targets are revealed, presenting an average target of $127.5, a high estimate of $171.00, and a low estimate of $99.00. This current average has decreased by ...Analysts have set 12-month price targets for BioNTech, revealing an average target of $145.43, a high estimate of $171.00, and a low estimate of $100.00. This upward trend is evident, with the ...BioNTech Q3 Profit Falls, Trims FY23 Vaccine Revenue Outlook. RTTNews. Nov. 6, 2023, 08:06 AM. (RTTNews) - BioNTech SE (BNTX) Monday announced a sharp fall in third-quarter earnings compared to ...BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June …3 Biotech Stock Sensations to Snatch up This Week. (Entrepreneur: Stocks) Jan-31-24 06:45AM. BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjugate Candidate BNT325/DB-1305. (GlobeNewswire) Jan-25-24 09:55AM. Jim Cramer is Recommending These 10 Stocks. (Insider Monkey) Jan-24-24 11:30AM.Answering this question will take us one step closer to our new normal. We know that the vaccines now available across the world will protect their recipients from getting sick wit...This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, but not limited to, statements concerning: BioNTech’s expected revenues and net profit/(loss) related to sales of BioNTech’s COVID-19 vaccine, referred to as COMIRNATY where approved for ...SPX. +0.48%. Shares of BioNTech SE sank toward a more than two-year low Wednesday, after the Germany-based biotechnology company reported fourth-quarter results that fell sharply below ...80.90%. -16.75%. -163.26%. -35.78%. -95.66%. Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC). Detailed annual and quarterly income statement for BioNTech SE (BNTX). See many years of revenue, expenses and profits or losses. Q1 2024 BioNTech SE Earnings Call. Find the latest BioNTech SE (BNTX) stock quote, history, news and other vital information to help you with your stock trading and investing. Still, the brothers are poised to lock in major gains after first providing BioNTech with €150 million ($186 million) in seed money when it was founded in 2008. The shares have climbed more than ...BioNTech to pay an upfront consideration of approximately £362 million in cash and BioNTech shares, to acquire 100% of remaining InstaDeep shares following BioNTech’s Series B investment in 2022Because of that gap in time -- and the risk of failures during clinical trials -- determining whether BioNTech stock is a buy is less about valuation and more about the open-ended potential of a ...BioNTech SE Sponsored ADR (BNTX) closed at $130.86 in the latest trading session, marking a -1.84% move from the prior day. This change lagged the S&P 500's daily gain of 0.31%.We are committed to improving the health of people worldwide with our fundamental research and development of immunotherapies. We believe in scientific rigor, innovation and passion as driving force. BioNTech was founded by scientists and physicians to translate science into survival by combining fundamental research and operational excellence ...Buy Moderna and BioNTech Stock. Both Pharmas Have Strong Drug Pipelines and Plenty of Cash. By Andrew Bary. Aug 18, 2023, 5:02 pm EDT. Share. Resize. Reprints.If BioNTech exercises an option, Autolus will be eligible to receive exercise fees and milestones payments, with low-single digit royalties on net sales of the licensed products. About BioNTech’s cell and gene therapy portfolio BioNTech has been active in the development of cell and gene therapies since 2009.Find the latest BioNTech SE (BNTX) stock quote, history, news and other vital information to help you with your stock trading and investing.Why BioNTech Stock Was Sinking Today. Why Shares of BioNTech Rose Friday. 2 Undervalued Stocks to Buy for Potentially Massive Gains in the Next 10 Years. Why Shares of BioNTech Slumped Monday.Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins an...The intraday chart, the last-five real-time quotes and sales data. Real-time stock quotes can be used to help inform investors when researching potential investment opportunities. BioNTech SE ...Group - Any - 3,4,5 Annual Filings Current Reports Mergers & Acquisitions Other Proxy Filings Quarterly Filings Registration Statements. Filing year - Any - 2024 2023 2022 2021 2020 2019. Items per page 10 25 50. Filing date.Discover real-time BioNTech SE American Depositary Share (BNTX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.Last Earnings Release. Mar. 20, 2024. Next Ex-Dividend Date. N/A. Last Ex-Dividend Date. Jun. 02, 2022. In depth view into BNTX (BioNTech) stock including the latest price, news, dividend history, earnings information and financials.PFE | Complete Pfizer Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.80.90%. -16.75%. -163.26%. -35.78%. -95.66%. Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC). Detailed annual and quarterly income statement for BioNTech SE (BNTX). See many years of revenue, expenses and profits or losses.NTLA Intellia Therapeutics, Inc. +0.51%. EDIT Editas Medicine, Inc. NVO Novo Nordisk A/S. +1.25%. View the basic BNTX option chain and compare options of BioNTech SE on Yahoo Finance.BioNTech, a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, has seen its stock decline by almost 9.4% over the last week (five trading days) and by about 17% over the ... BioNTech SE (BNTX) is a publicly traded biotechnology business based in the US. It opened the day at $92.56 after a previous close of $91.67. During the day the price has varied from a low of $92.4132 to a high of $93.48. The latest price was $92.72 (25 minute delay). BioNTech is listed on the NASDAQ and employs 6,133 staff. Get the latest price, news, and ratings for BioNTech SE ADR (BNTX), a German biotech company developing mRNA vaccines and cancer treatments. See how BNTX compares to its competitors and peers in the biotechnology industry. See BioNTech SE (BNTX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other
BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come. BioNTech stock lifted a fraction Monday after Covid vaccine sales dropped again in the first quarter, amid wide losses. Interactive chart for BioNTech SE (BNTX) – analyse all of the data with a huge range of indicators.Get the latest price, news, and ratings for BioNTech SE ADR (BNTX), a German biotech company developing cancer and covid vaccines. See its fair value …MAINZ, Germany and KRAKOW, Poland – November 30, 2022 – BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Ryvu Therapeutics S.A. (Warsaw Stock Exchange: RVU, “Ryvu”), a clinical-stage company developing oncology therapeutics today announced that the companies have entered into a multi-target research collaboration for several …Moderna stock and BioNTech led a sell-off Monday among Covid vaccine makers after Pfizer slashed about $9 billion from its full-year guidance.. X. Pfizer said it wrote off about $5.5 billion in ...How much is Biontech Se stock worth today? ( NASDAQ: BNTX) Biontech Se currently has 237,725,735 outstanding shares. With Biontech Se stock trading at $90.13 per share, the total value of Biontech Se stock (market capitalization) is $21.43B. Biontech Se stock was originally listed at a price of $14.24 in Oct 10, 2019.Mar 20, 2024 · SPX. +0.48%. Shares of BioNTech SE sank toward a more than two-year low Wednesday, after the Germany-based biotechnology company reported fourth-quarter results that fell sharply below ... BioNTech shares have soared 171.6% year to date through Friday and Pfizer's stock has lost 7.1%, while the S&P 500 SPX, -0.14% has gained 8.6%. Advertisement Read Next At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. The 12-month price targets, analyzed by analysts, offer insights with an average target of $116.6, a high estimate of $133.00, and a low estimate of $99.00. Experiencing a 11.83% decline, the ...DIS The Walt Disney Company. 105.35. -0.45%. Find the latest Pfizer Inc. (PFE) stock quote, history, news and other vital information to help you with your stock trading and investing.Mar 20, 2024 · The high end of the outlook lagged BioNTech stock analysts' forecast for $3.37 billion, according to FactSet. In response, BioNTech stock dropped to its lowest point since January 2021 ... The average analyst rating for BioNTech SE stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market ...BioNTech shares have soared 171.6% year to date through Friday and Pfizer's stock has lost 7.1%, while the S&P 500 SPX, -0.14% has gained 8.6%. Advertisement Read NextNEW YORK and MAINZ, GERMANY, MAY 26, 2023 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have reached an agreement with the European Commission (EC) to amend their existing contract to deliver COVID-19 vaccines to the European Union.. The amended agreement reflects the …80.90%. -16.75%. -163.26%. -35.78%. -95.66%. Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC). Detailed annual and quarterly income statement for BioNTech SE (BNTX). See many years of revenue, expenses and profits or losses.About BioNTech SE. BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June ...Feb 20, 2024 · Insights from analysts' 12-month price targets are revealed, presenting an average target of $127.5, a high estimate of $171.00, and a low estimate of $99.00. This current average has decreased by ... BNTX Competitors. $ Market cap P/E ratio $ Price 1d change 52-week range. View BioNTech SE Sponsored ADR BNTX stock quote prices, financial information, real-time forecasts, and company news from CNN.Advertisement. Shares of Pfizer and BioNTech surged on Monday after the FDA officially approved their COVID-19 vaccine. Pfizer jumped as much as 5% to near record highs, while BioNTech was up as ...Nov 6, 2023 · (RTTNews) - BioNTech SE (BNTX) Monday announced a sharp fall in third-quarter earnings compared to the prior year, as the commercial revenues were down sharply. The company revised down its COVID ... Pfizer, BioNTech stocks rise on report FDA could fully approve COVID-19 vaccine Last Updated: Aug. 20, 2021 at 7:01 p.m. ET First Published: Aug. 20, 2021 at 6:54 p.m. ET ByFeb 27, 2023 · BioNTech SE Sponsored ADR (BNTX) closed at $130.86 in the latest trading session, marking a -1.84% move from the prior day. This change lagged the S&P 500's daily gain of 0.31%. Analysts have set 12-month price targets for BioNTech, revealing an average target of $145.43, a high estimate of $171.00, and a low estimate of $100.00. This upward trend is evident, with the ...Cash Amount. Record Date. Pay Date. Jun 2, 2022. $2.111. Jun 3, 2022. Jun 17, 2022. * Dividend amounts are adjusted for stock splits when applicable. Get the latest dividend data for BioNTech SE (BNTX), including dividend history, yield, key dates, growth and other metrics. Complete BioNTech SE ADR stock information by Barron's. View real-time BNTX stock price and news, along with industry-best analysis. Monday, BioNTech SE (NASDAQ:BNTX) reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the consensus loss of 97 cents. The COVID-19 vaccine ...Find the latest BioNTech SE (BNTX) stock quote, history, news and other vital information to help you with your stock trading and investing.BioNTech reported Q4 2023 earnings below expectations, with EPS at €1.90 vs. €9.26 last year. Sales were €1.479 billion, missing consensus. Guidance for 2024 anticipates revenues of €2.5 ...BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific … Complete BioNTech SE ADR stock information by Barron's. View real-time BNTX stock price and news, along with industry-best analysis. Pfizer (PFE 1.19%) stock was down 3.5%. Shares of BioNTech (BNTX 2.14%) and Moderna (MRNA 0.66%) were sinking 7.6% and 8.2%, respectively. However, Pfizer and BioNTech actually had good news. The ...BioNTech Analyst EPS Estimates. BioNTech last announced its quarterly earnings results on March 20th, 2024. The reported $2.05 earnings per share for the quarter, missing the consensus estimate of $2.64 by $0.59. The company had revenue of $1.59 billion for the quarter, compared to analysts' expectations of $2.04 billion.6 days ago · Stock analysis for BioNTech SE (BNTX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Complete BioNTech SE ADR stock information by Barron's. View real-time BNTX stock price and news, along with industry-best analysis.BioNTech (BNTX) Stock Price, News & Analysis. → Millionaire investor and Republican donor makes surprising election prediction (From InvestorPlace) Free BNTX …On average, Wall Street analysts predict. that Biontech Se's share price could reach $113.57 by May 8, 2025. The average Biontech Se stock price prediction forecasts a potential upside of 23.37% from the current BNTX share price of $92.06.Apr 26, 2024 · BioNTech’s stock sinks after earnings miss, as inventory writedowns weigh Mar. 20, 2024 at 7:30 a.m. ET by Tomi Kilgore Biontech 4Q Rev EUR1.48B BioNTech plans to initiate a pivotal Phase 2 trial in relapsed/refractory germ cell tumors in 2024. In 2024, BioNTech intends to accelerate the development of its portfolio of next-generation investigational medicines both as monotherapies and in combination with immunotherapy agents and other targeted therapies across a wide range of tumor types. Pfizer Inc’s (NYSE:PFE) German partner, BioNTech SE (NASDAQ:BNTX), reported fourth-quarter 2023 EPS of fiscal year Q4 GAAP EPS of €1.90 versus €9.26, a year ago, equivalent to $2.04 missing ... SPX. +0.48%. Shares of BioNTech SE sank toward a more than two-year low Wednesday, after the Germany-based biotechnology company reported fourth-quarter results that fell sharply below ...About Pre-Market Quotes. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day. REAL TIME QUOTESAFTER MARKET QUOTES. BioNTech SE ...About Pre-Market Quotes. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day. REAL TIME QUOTESAFTER MARKET QUOTES. BioNTech SE ...BioNTech stock tumbled to its lowest point in three years Wednesday after the Covid vaccine maker reported light fourth-quarter sales and profit, and delivered lackluster 2024 guidance.. X. The ...Aug 7, 2023 · BNTX stock analysts projected a per-share loss of 30 cents. BioNTech blamed write-offs to partner Pfizer for the profit and sales hits. On today's stock market, BNTX stock toppled 7.5% to 98.50 ... A high-level overview of BioNTech SE (BNTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.BioNTech Analyst EPS Estimates. BioNTech last announced its quarterly earnings results on March 20th, 2024. The reported $2.05 earnings per share for the quarter, missing the consensus estimate of $2.64 by $0.59. The company had revenue of $1.59 billion for the quarter, compared to analysts' expectations of $2.04 billion.BioNTech ended 2023 with approximately €17.5 billion (unaudited) in cash, cash equivalents and security investments. The Company plans to maintain a strong financial position and generate ...BNTX: Biontech SE - Stock Price, Quote and News - CNBC. Biontech SE BNTX:NASDAQ. EXPORT. WATCHLIST +. RT Quote | Last NYSE Arca, VOL From …BNTX. -0.47%. On Monday, Evercore ISI began coverage on shares of BioNTech (NASDAQ: BNTX ), assigning an "In Line" rating and setting a price target of $100. The firm's analysis pointed to the ...BioNTech was among the first companies in the world to bring a viable COVID-19 vaccine to market. Check out for whom BNTX stock is a buy and why.How much is Biontech Se stock worth today? ( NASDAQ: BNTX) Biontech Se currently has 237,725,735 outstanding shares. With Biontech Se stock trading at $90.13 per share, the total value of Biontech Se stock (market capitalization) is $21.43B. Biontech Se stock was originally listed at a price of $14.24 in Oct 10, 2019.BioNTech reported Q4 2023 earnings below expectations, with EPS at €1.90 vs. €9.26 last year. Sales were €1.479 billion, missing consensus. Guidance for 2024 anticipates revenues of €2.5 ... BNTX Competitors. $ Market cap P/E ratio $ Price 1d change 52-week range. View BioNTech SE Sponsored ADR BNTX stock quote prices, financial information, real-time forecasts, and company news from CNN. May 7, 2024 · 5:53 AM. BioNTech (Filer) Form 6-K. Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. (Data available from 1/1/2016 forward) This page (NASDAQ:BNTX) was last updated on 5/8/2024 by MarketBeat.com Staff. Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods th...Stock analysis for BioNTech SE (BNTX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Company profile page for BioNTech SE including stock price, company news, executive